Search for: "Matter of Eli N." Results 21 - 40 of 173
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2017, 9:43 am
Having been distracted from the world of IP by his daughter's recent wedding, there has been some delay in this GuestKat's posting of the third instalment of his commentary on Eli Lilly v Actavis UK, [2017] UKSC 48. [read post]
29 Aug 2018, 11:50 am by Ilya Somin
I do not believe this claim is right as matter of original understanding. [read post]
6 Apr 2013, 11:18 am by Alfred Brophy
When I have a little more time I want to compare the subject matter of these essays to the subjects in the 1989 volume edited by Kermit Hall and James Ely, An Uncertain Tradition: Constitutionalism and the History of the South. [read post]
12 Mar 2013, 5:43 pm by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1340 (Fed. [read post]
2 Aug 2023, 7:00 am by Miquel Montañá (Clifford Chance)
Due to the creation of group Nº 2634, Daiichi, in October 2011, had to reduce the price of its original drug (Evista®) by approximately 40% to try to compete with the generic. [read post]
13 May 2015, 4:00 am by Administrator
Eli Lily and Company, 2015 ONCA 305 [55] This is not a bilateral context where Apotex is the only party that has been wronged by Lilly. [read post]
26 Jun 2013, 6:43 am
It only makes it plausible that N-terminal antibodies will be effective. [read post]
21 May 2014, 7:41 am by Larisa Vaysman
See, e.g., In re Spradlin, 231 B.R. 254, 256 n.1 (Bankr. [read post]